The presence of a shared deleterious variant and homozygous common variant in FGFBP2 in the proband and sons strongly implicates this cytotoxic T cell product in the pathophysiology of IgG4‐RD. This evidence concerns the gene FGFBP2 and immunoglobulin G4-related sclerosing disease.